CClinicalTrials.gg
Enrolling by invitationNCT06348758AIKnowledgeUpdated Apr 5, 2024

Knowledge, Attitudes, And Perceptions of a Group of Egyptian Dental Students Towards Artificial Intelligence

An observational study in Health Knowledge, Attitudes, Practice, sponsored by Cairo University. Enrolling by invitation at 1 site in Egypt. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-04-05.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
384
Ages
18 Years to 25 Years
Sex
All
01

Study summary

In the context of this ongoing AI revolution, it is essential to ensure that current and future clinical practitioners are up to date regarding this technology's current state and potential. It is valuable to assess the current attitude of clinical dentists and undergraduate students in dentistry regarding the future role of AI.

To the best of the author's knowledge, there is no study about Egyptian dental students' views and attitudes regarding the application of AI in dental practice. Therefore, this study aimed to evaluate the attitudes and perceptions of a group of dental students in Egypt towards AI.

Read the detailed description

Data will be collected using a questionnaire. The survey will be distributed to dental students at the Faculty of Dentistry, Cairo, and Egyptian Russian universities through Google Forms. The questionnaire comprised 3 sections and 22 questions. The survey consisted of a question on demographics and educational information about dental students, knowledge of and attitudes towards AI, future application areas of AI in dentistry, and topics of AI in dental education. The first part of the survey. Informed consent will be obtained from all the participants before completing the questionnaire.

02

Conditions studied

  • Health Knowledge, Attitudes, Practice
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Dental students in Egypt

Inclusion criteria

  • Dental students

Exclusion criteria

Exclusion Criteria:

  • Graduates
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
384 participants (estimated)
Patient registry
No

Groups and cohorts

  • Dental Students in Egyptian Dental schools

    Students should be in Egyptian Dental faculties. 1st year students will be excluded

    Other: questionnaire

Interventions

  • Otherquestionnaire

    E-Questionnaire will be sent to the students

06

What researchers measure

Primary outcomes

  1. knowledge, attitudes, and perceptions about artificial intelligence in Dentistry

    questionnaire

    Time frame: up to 6 months

07

Study locations

1 site
  • Cairo University- Faculty of Dentistry
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — The results of the survey will be published after statistical analysis

Supporting information: Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06348758
Lead sponsor
Cairo University
Responsible party
Reem Mohamed Fouad Wahby (Lecturer, Cairo University) — Principal investigator
First posted
Apr 5, 2024
Start date
Feb 11, 2024
Primary completion
Jun 7, 2024 (estimated)
Completion
Aug 7, 2024 (estimated)
Last update
Apr 5, 2024

Study contacts

Reem Wahby, PhD
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion